Evaluation of Efficacy and Failure of High Flow Nasal Cannula Therapy in Paediatric Emergency Service and Paediatric Intensive Care Unit High Flow Nasal Cannula Therapy In Paediatric Settings

Main Article Content

Gizem İleri
Neslihan Zengin
Alkan Bal


Objective: High-flow nasal cannula oxygen therapy (HFNC) improves gas exchange and decreases work of breathing in patients with acute respiratory distress. We aimed to discuss the indications for HFNC in children of all ages and diagnoses and to evaluate the efficacy and risk factors for failure of HFNC therapy in children with acute respiratory distress and failure in a paediatric emergency service and paediatric intensive care unit (PICU).

Material and Methods: A total of 191 patients aged one month to 18 years treated with HFNC between October 1, 2018, and July 1, 2020, in the Paediatric Emergency Service and PICU were included in the study. Demographic and clinical characteristics, underlying chronic diseases, HFNC treatment success, and treatment failure of the cases were recorded.  

Results: One hundred ninety-one children were included in the study, of whom 70 (36.6%) were female, and the median age was 13 months (1-204). The most common indication of HFNC treatment was bronchopneumonia (n=83, 43,5 %). HFNC treatment succeeded in 81.7 % (n=156) of the patients. It was observed that the two most successful patient groups were acute bronchiolitis and pneumonia. The failure rate was 18.3 % (35 of 191 children). The most common underlying comorbidity was bronchopulmonary dysplasia (BPD) (19, 9.9%). There was a statistically significant difference seen on Glasgow Coma Scale (GCS) and lactate value in blood gas in the first hour of the treatment in the group with unsuccessful results (p<0.05). During the HFNC treatment, 28 patients (14.7%) required invasive mechanical ventilation (IMV), and seven patients (3.7%) required non-invasive mechanical ventilation (NIMV).

Conclusion: HFNC is a reliable non-invasive treatment modality that is easily tolerated by children and has effective use in many critical diseases. Our study found that HFNC therapy could be initiated as the first-line therapy for various aetiologies of acute respiratory distress in a paediatric emergency service and PICU and all age groups. It was emphasized that transition to other treatment modalities should not be delayed in the cases predicted to be unsuccessful.


Download data is not yet available.

Article Details

How to Cite
İleri, G., Zengin, N., & Bal, A. (2022). Evaluation of Efficacy and Failure of High Flow Nasal Cannula Therapy in Paediatric Emergency Service and Paediatric Intensive Care Unit: High Flow Nasal Cannula Therapy In Paediatric Settings. Medical Science and Discovery, 9(4), 243–248. https://doi.org/10.36472/msd.v9i4.713
Research Article
Received 2022-04-04
Accepted 2022-04-15
Published 2022-04-17


Söğütlü Y, Biçer S, Kurt G et al. Outcomes of high flow nasal cannula oxygen therapy on the vital signs of children with lower respiratory tract diseases: a research article. Turkish Journal of Paediatric Emergency and Intensive Care Medicine 2016; 3: 121-130.

Sitthikarnkha P, Samransamruajkit R, Prapphal N et al. High flow nasal cannula versus conventional oxygen therapy in children with respiratory distress: a research article. Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine 2018; 22(5): 321-325.

Luo J, Duke T, Chisti M J et al. Efficacy of high flow nasal cannula vs. standard oxygen therapy or nasal continuous positive airway pressure in Children with respiratory distress: a meta-analysis. TheJournal of Paediatrics 2019;215: 199-208.

Slain K N, Shein S L, & Rotta A T. The use of high-flow nasal cannula in the paediatric emergency department. Jornal de Pediatria 2017; 93:36-45.

Schneider J, &Sweberg T. Acute respiratory failure. Critical Care Clinics 2013;29: 167-183.

Vural G, Tolunay O, & Tolunay İ. Evaluation of patients receiving high-flow nasal cannula oxygenation therapy in a paediatric ıntensive care unit. Turkish Journal of Intensive Care 2019; 0, 0-0.

Davison M, Watson M, Wockner L et al. Paediatric high-flow nasal cannula therapy in children with bronchiolitis: a retrospective safety andefficacy study in a non-tertiary environment: paedıatrıc hıgh-flow nasal cannula. Emergency Medicine Australasia 2017;29:198-203.

Kelly G S, Simon H K, &Sturm J J. High-flow nasal cannula use in children with respiratory distress in the emergency department: predicting the need for subsequent ıntubation. Paediatric Emergency Care 2013; 29: 888-892.

Kwon J W. High-flow nasal cannula oxygen therapy in children: a clinical review. Clinical and Experimental Paediatrics 2020; 63: 3-7.

Akyıldız B, Öztürk S, Ülgen-Tekerek ve ark. Comparison between high-flow nasal oxygen cannula and conventional oxygen therapy after extubation in paediatric intensive care unit. The Turkish Journal of Paediatrics 2018; 60: 126.

Hammer J. Acute respiratory failure in children. Paediatric Respiratory Reviews 2013; 14: 64-69.

Long E, Babl F E, & Duke T. Is there a role for humidified heated high-flow nasal cannula therapy in paediatric emergency departments, Emergency Medicine Journal 2016; 33: 386-389.

Chang C C, Lin Y C, Chen T C et al. High-Flow Nasal Cannula Therapy in Children With Acute Respiratory Distress With Hypoxia in A Paediatric Intensive Care Unit–A Single Center Experience, Frontiers in Paediatrics 2021; 9: 664180.

Asseri A A, AlQahtani Y A, Alhanshani A A et al. Indications and Safety of High Flow Nasal Cannula in Paediatric Intensive Care Unit: Retrospective Single Center Experience in SaudiArabia. Paediatric Health, Medicine and Therapeutics 2021; 12: 431-437.

D’Alessandro M, Vanniyasingam T, Patel A et al. Factors associated with treatment failure of high-flow nasal cannula among children with bronchiolitis: a single-centre retrospective study. Paediatrics& Child Health 2020; 26:229-235.

Franklin D, Babl F E, Schlapbach L J et al. A Randomized Trial of High-Flow Oxygen Therapy in Infants with Bronchiolitis. New England Journal of Medicine 2018; 378: 1121-1131.

Betters K A, Hebbar K B, McCracken C et al. A Novel Weaning Protocol for High-Flow Nasal Cannula in the PICU: Paediatric Critical Care Medicine 2017;18: 274-280.

Goh C T, Kirby L J, Schell D N et al. Humidified high-flow nasal cannula oxygen in bronchiolitis reduces need for invasive ventilation but not intensive care admission: High-flow nasal cannula in bronchiolitis. Journal of Paediatrics and Child Health 2017;53: 897-902.

McKiernan C, Chua L C, Visintainer P F et al. High Flow Nasal Cannula Therapy in Infants with Bronchiolitis. The Journal of Paediatrics 2010; 156: 634-638.

Mayordomo-Colunga J, Pons M, López Y et al. Predicting non-invasive ventilation failure in children from the SpO2/FiO2 (SF) ratio. Intensive Care Medicine 2013; 39: 1095-1103.

Kamit Can F, Anil A B, Anil M ve ark. Predictive factors for the outcome of high flow nasal cannula therapy in a paediatric intensive care unit: Is the SpO 2 /FiO 2 ratio useful Journal of Critical Care 2018; 44: 436-444.

Er A, Çağlar A, Akgül F et al. Early predictors of unresponsiveness to high-flow nasal cannula therapy in a paediatric emergency department. Paediatric Pulmonology 2018; 53: 809-815.

Kawaguchi A, Yasui Y, deCaen A et al. The Clinical Impact of Heated Humidified High-Flow Nasal Cannula on Paediatric Respiratory Distress: Paediatric Critical Care Medicine 2017; 18: 112-119.

Wing R, James C, Maranda L S et al. Use of High-Flow Nasal Cannula Support in the Emergency Department Reduces the Need for Intubation in Paediatric Acute Respiratory Insufficiency: Paediatric Emergency Care 2012; 28: 1117-1123.

Schibler A, Pham T M T, Dunster K R et al. Reduced intubation rates for infants after introduction of high-flow nasal prong oxygen delivery. Intensive Care Medicine 2011; 37:847-852.